Apotex Health Corp.(TSE:APTX)
CA$35.54+-0.36 (+3.07%)
TSE:APTX
Apotex Health Corp. financials statements
CA$35.54
At close:+-0.36 (+3.07%)
Want to see TSE:APTX full AI Analyst Report?
Apotex Health Corp. (APTX) Ratios
34 Followers
Apotex Health Corp. Ratios
TSE:APTX's free cash flow for Q? was ―. For the fiscal year, TSE:APTX's free cash flow was increased by ― and operating cash flow was ―. See a summary of the company’s cash flow.
| Ratios | Mar 26 | Mar 25 | Mar 24 |
|---|---|---|---|
| Liquidity Ratios | |||
| Current Ratio | 1.50 | 1.39 | 1.83 |
| Quick Ratio | 0.86 | 0.81 | 1.21 |
| Cash Ratio | 0.04 | 0.05 | 0.32 |
| Solvency Ratio | 0.10 | 0.06 | 0.00 |
| Operating Cash Flow Ratio | 0.44 | 0.33 | 0.43 |
| Short-Term Operating Cash Flow Coverage | 6.33 | 5.11 | 16.46 |
| Net Current Asset Value | C$ -2.93B | C$ -2.24B | C$ -861.82M |
| Leverage Ratios | |||
| Debt-to-Assets Ratio | 0.77 | 0.55 | 0.46 |
| Debt-to-Equity Ratio | -6.31 | 9.12 | 2.56 |
| Debt-to-Capital Ratio | 1.19 | 0.90 | 0.72 |
| Long-Term Debt-to-Capital Ratio | 1.24 | 0.87 | 0.64 |
| Financial Leverage Ratio | -8.14 | 16.70 | 5.51 |
| Debt Service Coverage Ratio | 2.23 | 1.55 | 0.85 |
| Interest Coverage Ratio | 3.24 | 2.50 | -0.03 |
| Debt to Market Cap | 0.47 | 0.34 | 0.21 |
| Interest Debt Per Share | 16.24 | 12.56 | 8.93 |
| Net Debt to EBITDA | 3.80 | 3.85 | 8.97 |
| Profitability Margins | |||
| Gross Profit Margin | 55.62% | 53.55% | 37.52% |
| EBIT Margin | 21.84% | 15.87% | 0.38% |
| EBITDA Margin | 26.12% | 19.94% | 5.51% |
| Operating Profit Margin | 22.52% | 16.49% | -0.16% |
| Pretax Profit Margin | 14.89% | 9.27% | -5.29% |
| Net Profit Margin | 10.71% | 4.53% | -5.00% |
| Continuous Operations Profit Margin | 10.71% | 4.53% | -5.00% |
| Net Income Per EBT | 71.90% | 48.84% | 94.45% |
| EBT Per EBIT | 66.12% | 56.23% | 3338.83% |
| Return on Assets (ROA) | 8.23% | 3.13% | -3.64% |
| Return on Equity (ROE) | -66.99% | 52.20% | -20.06% |
| Return on Capital Employed (ROCE) | 25.40% | 17.35% | -0.17% |
| Return on Invested Capital (ROIC) | 17.62% | 8.17% | -0.16% |
| Return on Tangible Assets | 10.71% | 4.00% | -3.84% |
| Earnings Yield | 5.97% | 2.46% | -2.38% |
| Efficiency Ratios | |||
| Receivables Turnover | 3.30 | 2.69 | 2.58 |
| Payables Turnover | 8.13 | 10.37 | 19.72 |
| Inventory Turnover | 1.67 | 1.60 | 2.21 |
| Fixed Asset Turnover | 3.09 | 2.93 | 2.65 |
| Asset Turnover | 0.77 | 0.69 | 0.73 |
| Working Capital Turnover Ratio | 5.06 | 3.80 | 0.00 |
| Cash Conversion Cycle | 284.84 | 328.98 | 288.13 |
| Days of Sales Outstanding | 110.60 | 135.79 | 141.30 |
| Days of Inventory Outstanding | 219.12 | 228.40 | 165.34 |
| Days of Payables Outstanding | 44.88 | 35.21 | 18.51 |
| Operating Cycle | 329.72 | 364.19 | 306.64 |
| Cash Flow Ratios | |||
| Operating Cash Flow Per Share | 2.77 | 2.43 | 2.50 |
| Free Cash Flow Per Share | 1.98 | 1.36 | 2.01 |
| Dividend Paid and CapEx Coverage Ratio | 0.50 | 1.36 | 5.12 |
| Capital Expenditure Coverage Ratio | 3.52 | 2.27 | 5.12 |
| Operating Cash Flow Coverage Ratio | 0.18 | 0.21 | 0.30 |
| Operating Cash Flow to Sales Ratio | 0.18 | 0.17 | 0.19 |
| Free Cash Flow Yield | 7.34% | 5.03% | 7.45% |
| Valuation Ratios | |||
| Price-to-Earnings (P/E) Ratio | 16.77 | 40.91 | -42.19 |
| Price-to-Sales (P/S) Ratio | 1.79 | 1.84 | 2.10 |
| Price-to-Book (P/B) Ratio | -11.21 | 21.23 | 8.42 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 13.63 | 19.88 | 13.43 |
| Price-to-Operating Cash Flow Ratio | 9.76 | 11.13 | 10.81 |
| Price-to-Earnings Growth (PEG) Ratio | 0.12 | -0.20 | 0.00 |
| Enterprise Value Multiple | 10.66 | 13.08 | 47.07 |
| Enterprise Value | 9.72B | 8.74B | 7.62B |
| EV to EBITDA | 10.66 | 13.08 | 47.07 |
| EV to Sales | 2.78 | 2.61 | 2.59 |
| EV to Free Cash Flow | 21.18 | 28.17 | 16.59 |
| EV to Operating Cash Flow | 15.17 | 15.77 | 13.35 |
| Tangible Book Value Per Share | -6.96 | -3.37 | 2.27 |
| Shareholders’ Equity Per Share | -2.41 | 1.27 | 3.21 |
| Tax and Other Ratios | |||
| Effective Tax Rate | 0.28 | 0.51 | 0.06 |
| Revenue Per Share | 15.06 | 14.66 | 12.87 |
| Net Income Per Share | 1.61 | 0.66 | -0.64 |
| Tax Burden | 0.72 | 0.49 | 0.94 |
| Interest Burden | 0.68 | 0.58 | -13.93 |
| Research & Development to Revenue | 0.05 | 0.06 | 0.06 |
| SG&A to Revenue | 0.15 | 0.15 | 0.16 |
| Stock-Based Compensation to Revenue | 0.02 | 0.02 | 0.02 |
| Income Quality | 1.71 | 3.65 | -3.89 |
Currency in CAD
